PhytoHealth Corporation (4108.TW)
TWD 16.15
(0.31%)
TWD 16.15
(0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -54.77 Million | -59.94 Million | -68.23 Million | -147.86 Million | -121.44 Million | -141.43 Million |
| Net Income | -74.14 Million | -114.72 Million | -95.51 Million | -116.26 Million | -204.76 Million | -208.77 Million |
| Depreciation & Amortization | 53.1 Million | 52.43 Million | 52.81 Million | 54.89 Million | 65.07 Million | 54.73 Million |
| Deferred income taxes | -74.05 Million | - | 16.82 Million | -14.43 Million | 8.82 Million | 49.39 Million |
| Stock-based compensation | 825 Thousand | 857 Thousand | 7.01 Million | -80 Thousand | 850 Thousand | 2.45 Million |
| Change in working capital | -34.65 Million | 1.58 Million | -40.95 Million | -66.41 Million | -14.81 Million | -30.72 Million |
| Other non-cash items | 74.14 Million | -110 Thousand | -8.42 Million | -5.56 Million | 23.37 Million | -8.51 Million |
| Investing Cash Flow | 26.24 Million | 76.92 Million | -581.14 Million | 109.7 Million | 102.77 Million | 152.81 Million |
| Investments in PPE | -4.73 Million | -1.6 Million | -13.21 Million | -1.53 Million | -7.03 Million | -64.09 Million |
| Acquisitions | -286 Thousand | - | - | 120.07 Million | - | 23.19 Million |
| Investment purchases | -67.61 Million | -194.76 Million | -754.23 Million | -164.61 Million | - | -97.34 Million |
| Sales/Maturities of investments | 97.17 Million | 273.69 Million | 185.97 Million | 156.67 Million | 110.4 Million | 298.33 Million |
| Other Investing Activities | 1.7 Million | -406 Thousand | 333 Thousand | -891 Thousand | -600 Thousand | -7.28 Million |
| Financing Cash Flow | -9.17 Million | -10.52 Million | 682.22 Million | -10.92 Million | -7.07 Million | 51.1 Million |
| Debt repayment | -71 Thousand | -117 Thousand | -363 Thousand | -113 Thousand | -224 Thousand | -1.42 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.32 Million | - | 700 Million | 56 Thousand | 2.47 Million | 2.43 Million |
| Other Financing Activities | -10.42 Million | -10.4 Million | -17.41 Million | -10.87 Million | -9.32 Million | 48.66 Million |
| Accounts receivables | -10.49 Million | -5.12 Million | -6.17 Million | -8.71 Million | 4.22 Million | 6.69 Million |
| Accounts payables | -3.22 Million | 3.68 Million | -1.99 Million | 1.53 Million | 187 Thousand | -18 Thousand |
| Inventory | -15.58 Million | -6.11 Million | -2.61 Million | -32.84 Million | -26.15 Million | 5.9 Million |
| Other working capital | -5.35 Million | 9.14 Million | -30.17 Million | -26.39 Million | 6.92 Million | -36.62 Million |
| Cash at beginning of period | 100.45 Million | 94 Million | 61.16 Million | 110.25 Million | 136 Million | 73.52 Million |
| Cash at end of period | 62.75 Million | 100.45 Million | 94 Million | 61.16 Million | 110.25 Million | 136 Million |
| Capital Expenditure | -4.73 Million | -1.6 Million | -13.21 Million | -1.53 Million | -7.03 Million | -64.09 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -37.7 Million | 6.45 Million | 32.84 Million | -49.09 Million | -25.74 Million | 62.47 Million |
| Free Cash Flow | -59.5 Million | -61.55 Million | -81.45 Million | -149.39 Million | -128.47 Million | -205.52 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.86 Million | -27.96 Million | -74.14 Million | -35.2 Million | -566 Thousand | -22.48 Million |
| Depreciation & Amortization | 13.5 Million | 13.59 Million | 53.1 Million | 13.32 Million | 13.32 Million | 13.26 Million |
| Deferred income taxes | - | - | -74.05 Million | -35.19 Million | 4.53 Million | 4.61 Million |
| Stock-based compensation | 267 Thousand | 266 Thousand | 825 Thousand | -201 Thousand | 765 Thousand | 151 Thousand |
| Change in working capital | -13 Million | 6.82 Million | -34.65 Million | 15.83 Million | -10.23 Million | -10.17 Million |
| Other non-cash items | 35.02 Million | -7.23 Million | 74.14 Million | 35.2 Million | -4.4 Million | -4.63 Million |
| Investing Cash Flow | 10.04 Million | 21.06 Million | 26.24 Million | 23.17 Million | -9.99 Million | -9.06 Million |
| Investments in PPE | -642 Thousand | - | -4.73 Million | -671 Thousand | -1.12 Million | -1.28 Million |
| Acquisitions | - | - | -286 Thousand | - | 286 Thousand | - |
| Investment purchases | -111.99 Million | -99.9 Million | -67.61 Million | 14.05 Million | 4.44 Million | -64.36 Million |
| Sales/Maturities of investments | 122.67 Million | 120.48 Million | 97.17 Million | 10 Million | -12.85 Million | 54.92 Million |
| Other Investing Activities | -327 Thousand | 479 Thousand | 1.7 Million | -213 Thousand | -749 Thousand | 1.66 Million |
| Financing Cash Flow | -2.84 Million | -2.55 Million | -9.17 Million | -1.29 Million | -2.62 Million | -2.63 Million |
| Debt repayment | - | -113 Thousand | -71 Thousand | -26 Thousand | -21 Thousand | -314 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 391 Thousand | 1.32 Million | 1.32 Million | - | - |
| Other Financing Activities | -2.84 Million | 391 Thousand | -10.42 Million | -2.59 Million | -2.6 Million | -2.31 Million |
| Accounts receivables | -9.15 Million | 5.44 Million | -10.49 Million | 57 Thousand | -3.85 Million | -3.59 Million |
| Accounts payables | 3.9 Million | 466 Thousand | -3.22 Million | -260 Thousand | -2.71 Million | -383 Thousand |
| Inventory | -9.96 Million | 15.94 Million | -15.58 Million | 14.35 Million | -11.78 Million | -3.28 Million |
| Other working capital | 2.2 Million | -15.03 Million | -5.35 Million | 1.68 Million | 8.11 Million | -2.91 Million |
| Cash at beginning of period | 61.15 Million | 62.75 Million | 100.45 Million | 47.11 Million | 56.3 Million | 87.26 Million |
| Cash at end of period | 45.78 Million | 61.15 Million | 62.75 Million | 62.75 Million | 47.11 Million | 56.3 Million |
| Capital Expenditure | -642 Thousand | - | -4.73 Million | -671 Thousand | -1.12 Million | -1.28 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -15.36 Million | -1.6 Million | -37.7 Million | 15.63 Million | -9.19 Million | -30.95 Million |
| Free Cash Flow | -23.21 Million | -20.1 Million | -59.5 Million | -6.9 Million | 2.3 Million | -20.54 Million |
0450
STP
IFX
1821
1809
WRB-PF